Press monitoring

Recombinant bacterium boosts production of compound that can relieve menopause symptoms

1.2.2016   |   Press monitoring

A soy isoflavone derivative that goes by the scientific moniker, (S)-equol, has proven potent for mitigating menopausal symptoms. However, it has been impossible to produce in quantities sufficient for widespread commercial nutraceutical production. But now, a team of Korean researchers reports having constructed a recombinant bacterium which...

Continue


Novartis Foundation commemorates World Leprosy Day with its continued efforts to go the last mile toward elimination

31.1.2016   |   Press monitoring

Basel, January 31, 2016 - On World Leprosy Day 2016, the Novartis Foundation calls for a greater global commitment to the fight against leprosy to support efforts towards zero transmission of the disease and to reduce stigma. The Novartis Foundation continues to work with partners around the world on early detection and treatment of leprosy,...

Continue


Actelion receives positive CHMP opinion for Uptravi (selexipag) for the long-term treatment of pulmonary arterial hypertension

29.1.2016   |   Press monitoring

ALLSCHWIL, SWITZERLAND - 29 January 2016 - Actelion (SIX: ATLN) announced today that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), issued a positive opinion for the use of the orally active, selective IP prostacyclin receptor agonist Uptravi (selexipag), originally...

Continue


Seagrass genome sequence lends insights to salt tolerance

29.1.2016   |   Press monitoring

International team sequenced a seagrass genome: that of the eelgrass Zostera marina, taken from the Archipelago Sea off Finland. Despite the name, eelgrasses aren't true grasses but rather completely submerged marine flowering plants, or angiosperms, and members of an ancient monocot family. To better understand the adaptations the plant made in...

Continue


LivaNova Receives Regulatory Approval in Japan for KORA 250

28.1.2016   |   Press monitoring

LONDON, Jan. 28, 2016 (GLOBE NEWSWIRE) -- LivaNova, PLC (NASDAQ:LIVN) (LSE:LIVN) (the "Company"), a leading global medical technology company, announced today the approval of its new generation of full body MRI (Magnetic Resonance Imaging) conditional pacemakers by PMDA in Japan. KORA 250 SR and DR pacemakers allow patients to undergo MRI scans...

Continue


Hand sanitizer, antifreeze can preserve DNA

27.1.2016   |   Press monitoring

A few simple products, such as hand sanitizer and antifreeze, can preserve DNA in samples collected by lay people for scientific research, a new University of Florida study shows. "This is great news because unlike high-concentration chemicals, such as 95 percent ethanol or pure propylene glycol -- which are expensive and hard to access -- these...

Continue


Affimed Enters into Collaboration with Merck to Evaluate AFM13 in Combination with KEYTRUDA® (pembrolizumab) for Patients with Hodgkin Lymphoma

25.1.2016   |   Press monitoring

Heidelberg, Germany, January 25, 2016 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that it has entered into a clinical research collaboration in immuno-oncology with Merck (NYSE: MRK), known as MSD outside the United States...

Continue


New method for making biofuels is cheaper and better for the environment

25.1.2016   |   Press monitoring

Chemical and Biomolecular Engineers from the Melbourne School of Engineering have discovered a new way to deliver carbon dioxide to microalgae, which in turn, can be harvested to make renewable fuels such as biodiesel. Carbon dioxide is well known to speed up the growth of microalgae. However, the carbon dioxide has to be free of contamination or...

Continue


PCI Biotech: Dose escalation in the bile duct cancer study completed with promising early signs of efficacy

22.1.2016   |   Press monitoring

Oslo, 22 January 2016 - PCI Biotech (PCIB) reported today that the treatment evaluation of the fourth dose cohort in the Phase I/II study of fimaporfin (Amphinex®) in patients with inoperable bile duct cancer has been completed. The Cohort Review Committee (CRC) of clinical experts and company representatives has recommended that the study...

Continue


No sex required: Gene trigger for asexual reproduction discovered

22.1.2016   |   Press monitoring

A German-Israeli team led has discovered a gene trigger in the moss Physcomitrella patens which leads to offspring without fertilization. The researchers assume that this mechanism is conserved in evolution and holds the key to answer fundamental questions in biology. "Just like humans and animals, mosses possess egg cells and motile sperm. That...

Continue


 

CEBIO

  • CEBIO
  • BC AV CR
  • Budvar
  • CAVD
  • CZBA
  • Eco Tend
  • Envisan Gem
  • Gentrend
  • JAIP
  • Jihočeská univerzita
  • Madeta
  • Forestina
  • ALIDEA

LinkedIn
TOPlist